| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 06/17/1998 | CN1185112A Use of flavanolignanes for the prepn. of medicametns with antiproliferative activity in uterus, ovary and breast |
| 06/17/1998 | CN1185109A Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 06/16/1998 | US5767251 Polypeptides |
| 06/16/1998 | US5767139 Skin disorders; alopecia; prostate cancer |
| 06/16/1998 | US5767116 Bicyclic aromatic compounds as therapeutic agents |
| 06/16/1998 | US5767067 Follicle stimulating hormone and pharmaceutical compositions containing same |
| 06/11/1998 | WO1998024809A1 Peptides agonists of bradykinine b2 receptor |
| 06/11/1998 | WO1998024791A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| 06/11/1998 | WO1998024442A1 Use of nk-1 receptor antagonists for treating sexual dysfunction |
| 06/11/1998 | CA2273351A1 Use of nk-1 receptor antagonists for treating sexual dysfunction |
| 06/11/1998 | CA2273190A1 Peptides agonists of bradykinine b2 receptor |
| 06/11/1998 | CA2272330A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| 06/11/1998 | CA2224131A1 Novel human 11 cb splice variant |
| 06/10/1998 | EP0846466A2 Compositions for the treatment of rheumatoid-based arthritic diseases |
| 06/10/1998 | EP0846118A1 Cyclic gmp-specific phosphodiesterase inhibitors |
| 06/10/1998 | EP0845985A1 Non-steroidal sulfatase inhibitor compounds and their method of use |
| 06/10/1998 | EP0674508B1 4-guanidinobutyramide for improving blood circulation |
| 06/10/1998 | CN1184470A Thienyl-, Furyl-, Pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 06/10/1998 | CN1184407A Stress regulator for animals |
| 06/10/1998 | CN1183987A Gynaecologist's hemostatic |
| 06/09/1998 | US5763567 Human amino acid sequences which can bind to and/or neutralize heparin |
| 06/09/1998 | US5763484 Metabolites of linoleic acid and a-linolenic acid |
| 06/09/1998 | US5763458 1-phenylalkanone 5-HT4 receptor ligands |
| 06/09/1998 | US5763448 Schizophrenia |
| 06/09/1998 | US5763420 Method for modulating the immune system |
| 06/09/1998 | US5763404 Methods for using LHRH antagonists with low histamine release |
| 06/09/1998 | US5763399 Revitalizing tissues with growth factor |
| 06/04/1998 | WO1998023636A1 Heptapeptide oxytocin analogues |
| 06/04/1998 | WO1998023619A1 Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases |
| 06/03/1998 | EP0845035A2 Urocortin peptides |
| 06/03/1998 | EP0844880A2 Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation |
| 06/03/1998 | EP0844876A1 Endometrial ablation using photodynamic therapy with green porphyrins |
| 06/03/1998 | EP0804209A4 Chemical castration |
| 06/03/1998 | CN1183786A Bicyclic tachykinins antagonists, preparation thereof and their use in autagonistes composition |
| 06/03/1998 | CN1183726A Synthetic cryptophycins |
| 06/03/1998 | CN1183291A 治疗前列腺疾病的康舒药物 Drug treatment of prostate disease Glands |
| 06/03/1998 | CN1183281A Ointment contg. low-molecular heparin and its preparing method |
| 06/03/1998 | CN1038586C Process for preparing pyrazine derivs |
| 06/02/1998 | US5760248 Having improved metabolic stability |
| 06/02/1998 | US5760073 Treatment of central nervous system disorders |
| 06/02/1998 | US5760061 Using a benzothiophene compound |
| 06/02/1998 | US5760060 Methods of inhibiting ovarian dysgenesis, delayed puberty, or sexual infantilism |
| 06/02/1998 | US5760054 Alpha IC adrenergic receptor antagonists |
| 06/02/1998 | US5760051 Central nervous system |
| 06/02/1998 | US5760025 Administering testosterone 5a-reductase inhibitors |
| 06/02/1998 | US5760014 Administering a blend of dextrose, dextrin, maltodextrin or mixtures with starches |
| 05/28/1998 | WO1998022465A1 A1 adenosine receptor antagonists |
| 05/28/1998 | WO1998022138A1 Method for treating symptoms of diabetes |
| 05/28/1998 | WO1998022122A1 Alkyl peptide amides and applications |
| 05/28/1998 | WO1998022101A2 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 05/28/1998 | DE19649460A1 Neue substituierte Pyrazolderivate New substituted pyrazole derivatives |
| 05/28/1998 | CA2633660A1 Method for treating symptoms of diabetes |
| 05/28/1998 | CA2272865A1 Alkyl peptide amides and applications |
| 05/27/1998 | EP0843556A1 Glyceryl poly(meth)acrylate type gel based pharmaceutical compositions |
| 05/27/1998 | CN1182619A External used ointment for curing dermatosis, venereal disease and AIDS and preparation method thereof |
| 05/27/1998 | CN1182592A Stable prostaglandin E1-containing injectable composition |
| 05/27/1998 | CN1038505C Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same |
| 05/26/1998 | US5756818 Hydrogenation; protecting; deprotecting; clathrates |
| 05/26/1998 | US5756668 Hypermethylated in cancer polypeptide, HIC-1 |
| 05/26/1998 | US5756503 Analgesics, anesthetics, antiinflammatory agents |
| 05/26/1998 | US5756490 Estrogen and gestagen |
| 05/22/1998 | WO1998021237A2 Peptide compounds useful for modulating fgf receptor activity |
| 05/22/1998 | WO1998021229A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them |
| 05/22/1998 | WO1998020872A1 Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections |
| 05/22/1998 | CA2271843A1 Topical formulations containing as a therapeutic active agent fatty acids or fatty alcohols or monoglyceride derivatives thereof for treating of mucosa infections |
| 05/22/1998 | CA2270871A1 Peptide compounds useful for modulating fgf receptor activity |
| 05/22/1998 | CA2270158A1 Conformationally constrained lh-rh analogues, their uses and pharmaceutical compositions containing them |
| 05/20/1998 | EP0843016A2 Staphylococcus FabD (malonylCoA:ACP transacylase) protein |
| 05/20/1998 | EP0843011A2 RsbU-1 derived from Staphylococcus |
| 05/20/1998 | EP0842946A1 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them |
| 05/20/1998 | EP0841935A1 Modulation of endothelial cell proliferation |
| 05/20/1998 | EP0741708B1 Cyanoguanidines as k-channel blockers |
| 05/20/1998 | CN1182368A Immanomodulating compositions from bile for treatment of immune system disorders |
| 05/20/1998 | CN1182366A Use of nitric oxide donors or nitric oxide inhibitors for regulation cervical dilatation and extensiblity |
| 05/20/1998 | CN1181933A Preparation of bacteria-free freezing-dried prostaglandin E1 powder injection |
| 05/20/1998 | CN1038413C Prep. of amides for treatment |
| 05/19/1998 | US5753710 Substituted benzyloxycarbonylguanidines, a process for their preparation, their use as a medicament or diagnostic, and a medicament containing them |
| 05/19/1998 | US5753648 Tricyclic benzazepine vasopressin antagonists |
| 05/19/1998 | US5753641 Method of treatment for benign prostatic hyperplasia |
| 05/19/1998 | US5753266 Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases |
| 05/19/1998 | US5752974 Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
| 05/14/1998 | WO1998019996A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
| 05/14/1998 | WO1998019672A1 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/14/1998 | WO1998006427A3 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 05/14/1998 | WO1998005776A3 Secreted proteins and polynucleotides encoding them |
| 05/14/1998 | CA2271013A1 Nitric oxide donor compounds and pharmaceutical compositions for pulmonary hypertension and other indications |
| 05/14/1998 | CA2270118A1 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 05/13/1998 | EP0840732A1 Substituted benzolactam compounds as substance p antagonists |
| 05/13/1998 | EP0840728A1 Heteroaryl diol acids as leukotriene antagonists |
| 05/13/1998 | EP0840622A1 Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity |
| 05/13/1998 | EP0840616A1 Soluble lymphotoxin-beta receptors and anti-lymphotoxin receptor and ligand antibodies, as therapeutic agents for the treatment of immunological disease |
| 05/13/1998 | EP0840608A1 Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 05/13/1998 | EP0840599A1 Pharmaceutical compositions of conjugated estrogens and methods for their use |
| 05/13/1998 | EP0668872B1 Calcium channel blocking polypeptides from theraphosidae aphonopelma |
| 05/13/1998 | CN1181700A Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 05/12/1998 | US5750712 Diabetic therapy |
| 05/12/1998 | US5750693 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 05/12/1998 | US5750687 Angiotensin converting enzyme inhibitors, neutral endopeptidase inhibitors |
| 05/12/1998 | US5750557 Method and pharmaceutical formulation for treating benign prostatic hyperplasia |
| 05/12/1998 | US5750554 Compounds for treatment of anxiety, depression, antisecretory agents, hypotensive agents and treatment of eating problems |